-+ 0.00%
-+ 0.00%
-+ 0.00%

Eton Pharmaceuticals FY2026 Revenue expected to be more than $120.000M vs $113.804M Est

Benzinga·05/14/2026 20:10:53
Listen to the news
Eton Pharmaceuticals (NASDAQ:ETON) FY2026 Revenue expected to be more than $120.000M vs $113.804M Est